Eli Lilly (LLY) Selects ICON plc (ICLR) to Manage Clinical Trial Site Set Up and Monitoring in Europe
More News related to ICLR
- ICON Selected by Lilly to Oversee its Clinical Data Management in Japan
- ICON (ICLR) Posts Q3 EPS of $0.40; Guides FY09 EPS Above Street
- ICON Reports 14% Increase in EPS, and Raises Earnings Guidance for 2009
- Trading Radar for 10/21: Boeing (BA), eBay (EBAY), Wells Fargo (WFC), US Bancorp (USB), Eli Lilly (ELY), St. Jude Medical (STJ) Report
- Goldman Sachs Downgrades Parexel (PRXL) to Sell, Upgrades Charles River (CRL) to Neutral
More News related to LLY
- NOXXON Pharma AG Achieves Milestone in Partnership with Eli Lilly and Company
- Generic Erosion of Established Branded Atypical Antipsychotics Will Cause the Schizophrenia Drug Market To Decline More Than $1 Billion by 2013
- Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry
- Goldman Sachs Removed Abbott Labs (ABT) From Buy List, Eli Lilly (LLY) From Sell List
- FDA Approves Cymbalta (LLY) for Treatment of Generalized Anxiety Disorder
More News related to Corporate News
- UnitedHealth (UNH) Granted Preliminary Approval in $350M Class Action Lawsuit
- Upside in AMD (AMD) Shares Intensifies, Stock Now Up 8%+ to a New 52-Week High
- Wegener (WGNR) Receives Nasdaq Notice, Going Concern Audit Opinion
- IBM (IBM) and Vanderlande Ind. Sign Four-Year Contract with Amsterdam Airport Schiphol
- General Dynamics (GD) Business Unit Awarded $54M U.S. Marine Corps for 24 Additional COCs
ICON plc, (NASDAQ: ICLR) today announced that it has signed a strategic partnership with Eli Lilly and Company (NYSE: LLY) to manage the company's clinical trial site set up and monitoring in Europe for Lilly managed studies. The agreement, which is subject to the relevant employee consultation processes, is a continuation of Lilly's ongoing transformation of its research and development organisation and follows Lilly's selection of ICON to manage its clinical data management business outside of the US, which was announced in November 2008.
Related Categories
Corporate NewsStocks Mentioned
+0.04Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
